STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Current Quarter	$0.04	Next Quarter	$0.01
Current Year	$-0.03	Next Year	$0.22
QoQ Growth	-75.0%	YoY Growth	+833.3%
3Y EPS CAGR	-100.0%	Target Price	$30.22
Consensus	Buy	Upside	-9.4%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	STAA	$33.34	+2.68%	947.26K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	STAA	$33.34	+2.7%	947.26K
3
4
5
6

STAA

STAA

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get STAAR Surgical Company Data in Excel

Get STAAR Surgical Company Data in Excel